These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deleterious versus protective autoimmunity in multiple sclerosis. Kostic M, Stojanovic I, Marjanovic G, Zivkovic N, Cvetanovic A. Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389 [Abstract] [Full Text] [Related]
4. [Pathogenesis of multiple sclerosis: status of research]. Hartung HP. Wien Med Wochenschr; 1996 Aug; 146(19-20):520-7. PubMed ID: 9082652 [Abstract] [Full Text] [Related]
5. Insights into the immunopathogenesis of multiple sclerosis. Hellings N, Raus J, Stinissen P. Immunol Res; 2002 Aug; 25(1):27-51. PubMed ID: 11868933 [Abstract] [Full Text] [Related]
6. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Carson MJ. Glia; 2002 Nov; 40(2):218-231. PubMed ID: 12379909 [Abstract] [Full Text] [Related]
10. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Murphy AC, Lalor SJ, Lynch MA, Mills KH. Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983 [Abstract] [Full Text] [Related]
13. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination. Bajramović JJ, Plomp AC, Goes Av, Koevoets C, Newcombe J, Cuzner ML, van Noort JM. J Immunol; 2000 Apr 15; 164(8):4359-66. PubMed ID: 10754336 [Abstract] [Full Text] [Related]